Compare Stocks

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BLU BELLUS Health	$14.74	$14.62	$6.38 ▼ $14.76	$1.87B	0.19	3.08 million shs	3.45 million shs
CDH Corridor Resources		C$1.38	C$0.62 ▼ C$1.48	C$121.64M	N/A	528,295 shs	103,002 shs
GEV GE Vernova	$151.91 +2.4%	$0.00	$115.00 ▼ $157.25	$41.33B	N/A	6.90 million shs	2.46 million shs
MVN Madalena Energy	C$0.08 -5.9%	C$0.08	C$0.08 ▼ C$0.21	C$43.53M	N/A	114,547 shs	111,000 shs

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BLU BELLUS Health	0.00%	0.00%	0.00%	0.00%	+1.80%
CDH Corridor Resources	0.00%	0.00%	0.00%	0.00%	0.00%
GEV GE Vernova	+1.42%	+8.08%	+14,830,999,900.00%	+14,830,999,900.00%	+14,830,999,900.00%
MVN Madalena Energy	0.00%	0.00%	0.00%	0.00%	0.00%

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BLU BELLUS Health	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CDH Corridor Resources	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GEV GE Vernova	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MVN Madalena Energy	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BLU BELLUS Health	N/A	N/A	N/A	N/A
CDH Corridor Resources	N/A	N/A	N/A	N/A
GEV GE Vernova	2.78	Moderate Buy	$157.44	3.64% Upside
MVN Madalena Energy	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest CDH, MVN, BLU, and GEV Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/24/2024	GEV GE Vernova	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$150.00
4/22/2024	GEV GE Vernova	Melius Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$147.00
4/18/2024	GEV GE Vernova	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$174.00
4/17/2024	GEV GE Vernova	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$177.00
4/17/2024	GEV GE Vernova	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$160.00
4/16/2024	GEV GE Vernova	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$154.00
4/15/2024	GEV GE Vernova	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$154.00
4/12/2024	GEV GE Vernova	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$160.00
4/8/2024	GEV GE Vernova	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$141.00
4/2/2024	GEV GE Vernova	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral ➝ Neutral	$141.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BLU BELLUS Health	$15K	124,613.93	N/A	N/A	$3.09 per share	4.77
CDH Corridor Resources	C$10.27M	0.00	N/A	1.44	C$1.28 per share	0.00
GEV GE Vernova	$33.24B	1.24	N/A	N/A	N/A	∞
MVN Madalena Energy	C$28.29M	1.54	C$0.00 per share	30.00	C$0.06 per share	1.33

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BLU BELLUS Health	-$76.08M	-$0.72	N/A	N/A	N/A	-578,586.63%	-24.27%	-23.14%	N/A
CDH Corridor Resources	N/A	C$0.08	16.63	N/A	N/A	N/A	N/A	N/A	N/A
GEV GE Vernova	-$438M	N/A	0.00	46.17	N/A	N/A	N/A	N/A	7/25/2024 (Estimated)
MVN Madalena Energy	N/A	-C$0.00	N/A	∞	N/A	N/A	N/A	N/A	N/A

Latest CDH, MVN, BLU, and GEV Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/25/2024	Q1 2024	GEV GE Vernova	-$0.24	-$0.41	-$0.17	-$0.35	$7.56 billion	$7.26 billion

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BLU BELLUS Health	N/A	N/A	N/A	N/A	N/A
CDH Corridor Resources	N/A	N/A	N/A	N/A	N/A
GEV GE Vernova	N/A	N/A	N/A	N/A	N/A
MVN Madalena Energy	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BLU BELLUS Health	N/A	33.42	33.42
CDH Corridor Resources	0.28	69.35	67.53
GEV GE Vernova	N/A	0.94	0.65
MVN Madalena Energy	17.24	0.84	0.53

Ownership

Institutional Ownership

Company	Institutional Ownership
BLU BELLUS Health	90.37%
CDH Corridor Resources	N/A
GEV GE Vernova	N/A
MVN Madalena Energy	N/A

Insider Ownership

Company	Insider Ownership
BLU BELLUS Health	24.17%
CDH Corridor Resources	N/A
GEV GE Vernova	N/A
MVN Madalena Energy	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BLU BELLUS Health	74	126.81 million	96.16 million	Not Optionable
CDH Corridor Resources	11	88.15 million	N/A	Not Optionable
GEV GE Vernova	80,000	272.06 million	N/A	N/A
MVN Madalena Energy	93	544.06 million	N/A	Not Optionable

CDH, MVN, BLU, and GEV Headlines

Source	Headline
	Madalena Energy (CVE:MVN) Stock Passes Above 200-Day Moving Average of $0.08 americanbankingnews.com - April 26 at 3:40 AM
	Madalena Energy (CVE:MVN) Stock Passes Above 200 Day Moving Average of $0.08 americanbankingnews.com - April 18 at 3:06 AM
	Review: Maven Lane newsobserver.com - October 8 at 5:45 PM
	Maven build automation tool review techrepublic.com - June 27 at 2:19 PM
	Why Maven Clinic is the highest-valued startup in women’s health fastcompany.com - March 4 at 6:42 PM
	MAVEN status update phys.org - February 26 at 4:45 PM
	Centaurus Energy Inc (CTA) NPV hl.co.uk - January 14 at 5:51 PM
	Maven Clinic, women and family-focused health startup, is booming in the post-Roe v. Wade world cnbc.com - October 29 at 7:03 AM
	Centaurus Energy Inc (CTARF) uk.investing.com - October 6 at 12:21 AM
	Petronas Gas Bhd (PGAS) investing.com - November 3 at 12:55 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
GE Aerospace is Ready for Liftoff After Strong Earnings
April 24, 2024 9:07 AM
View GE Aerospace is Ready for Liftoff After Strong Earnings
5 High Short Interest Stocks Getting Squeezed With Upside To Go
April 5, 2024 9:25 AM
View 5 High Short Interest Stocks Getting Squeezed With Upside To Go
Buy the Dip in Netflix Stock, It Won’t Last Long
April 19, 2024 8:32 AM
View Buy the Dip in Netflix Stock, It Won’t Last Long
Comprehensive PepsiCo Stock Analysis
April 18, 2024 12:05 PM
View Comprehensive PepsiCo Stock Analysis

All Headlines

Company Descriptions

BELLUS Health

NASDAQ:BLU

BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.

Corridor Resources

TSE:CDH

Corridor Resources Inc., a junior resource company, explores for, develops, and produces petroleum and natural gas. The company explores for petroleum and natural gas onshore in New Brunswick and Québec; and offshore in the Gulf of St. Lawrence. Its principal properties include the McCully Field located to the northeast of Sussex, New Brunswick; the Frederick Brook Shale located in the Elgin sub-basin in southern New Brunswick; and the Old Harry prospect located in the Gulf of St. Lawrence. As at December 31, 2017, the company had an interest in 38 net producing and nonproducing natural gas and oil wells. Corridor Resources Inc. was founded in 1983 and is headquartered in Halifax, Canada.

GE Vernova

NYSE:GEV

GE Vernova LLC, an energy business company, generates electricity. It operates under three segments: Power, Wind, and Electrification. The Power segments generates and sells electricity through hydro, gas, nuclear, and steam power. Wind segment engages in the manufacturing and sale of wind turbine blades; and Electrification segment provides grid solutions, power conversion, solar, and storage solutions. The company was incorporated in 2023 and is based in Cambridge, Massachusetts. GE Vernova operates as a subsidiary of General Electric Company.

Madalena Energy

CVE:MVN

Madalena Energy Inc. explores for, develops, and produces crude oil, natural gas liquids, and natural gas. It primarily holds interest in the Surubi Block covering an area of 90,824 acres located in the Northwest Basin, Argentina; Puesto Morales Block that covers an area of 59,671 acres located in the Neuquén Basin, Argentina; and Coiron Amargo Norte concession located in the Neuquén Basin of Argentina. The company was formerly known as Madalena Ventures Inc. and changed its name to Madalena Energy Inc. in August 2013. Madalena Energy Inc. is headquartered in Buenos Aires, Argentina.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial